A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2006
08/30/2006	CN1823775A Stable palonosetron injection liquid and its preparation method
08/30/2006	CN1823771A FK506 oral medicinal composition
08/30/2006	CN1823756A Effervescent tablet containing lysine hydrochloride, inositol and vitamin B12 and its preparation method
08/30/2006	CN1823745A Patch
08/30/2006	CN1823744A Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same
08/30/2006	CN1823742A Preparation method of medicinal single layer core osmotic pump tablet
08/30/2006	CN1823740A Taxadol slow release nano-particle, its preparation method and application
08/30/2006	CN1823737A Porous drug matrices and methods of manufacture thereof
08/30/2006	CN1823736A Process to make a sustained release formulation
08/30/2006	CN1823735A Self assembled precusor liposome containing hard soluble medicine and its preparation method
08/30/2006	CN1823734A Taxdol self assembled precusor liposome and its preparation method
08/30/2006	CN1823733A Self asembled precusor liposome containing camptothecin kind medicine and its preparation method
08/30/2006	CN1823732A Poly olefinic taxadol self assembled precusor liposome and its preparation method
08/30/2006	CN1823731A Esters of l-carnitine of alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
08/30/2006	CN1823730A Molecular coating method of plant polyphenol kind substance
08/30/2006	CN1823729A Butyl benzene phthalein vein emulsion and its application
08/30/2006	CN1823728A Fast film forming medical film coating liquid possessing antiseptic and/or treating action
08/30/2006	CN1823727A Intestine target medicinal controlled release fiber and its preparation method
08/30/2006	CN1823726A Degradable temperature sensitive physical aquagel and its preparation method
08/30/2006	CN1823725A Aerosol pharmaceutical compositions
08/30/2006	CN1272072C Triple combination of Planick-cholate phosphate in use for carrier of hard-soluble medication
08/30/2006	CN1272071C External medicine for wounds
08/30/2006	CN1272069C Stabilizing medicinal agent containing ciliary nerve nutritive factor analogue
08/30/2006	CN1272022C Composition for treatment of articular cartilage damage
08/30/2006	CN1272015C Adefovir dipivoxil and polyethylene glycol fused matter and its preparation method
08/30/2006	CN1272010C Powdery respiratory tonic composition
08/30/2006	CN1272002C Supermolecular intercalation-structure slow-release captopril and its preparing method
08/30/2006	CN1271992C Cationic virosomes as transfer system for genetic material
08/29/2006	US7098305 Sustained release of microcrystalline peptide suspensions
08/29/2006	US7098302 Epidermal growth factor receptor; prevention and treatment of disorders associated with overexpression of ErbB2 (e.g., breast cancer).
08/29/2006	US7098197 An antiviral nucleoside in which the 5'-hydroxyl group has been substituted for a phosphonate or methyl phosphonate that is covalently linked to an alkylethanediol; osteoporosis; anticarcinogenic agents; viricides
08/29/2006	US7098193 Useful for the treatment of gastrointestinal conditions
08/29/2006	US7098190 Formulations comprising antisense nucleotides to connexins
08/29/2006	US7098032 Delivering a nucleic acid to a cell; condensing nucleic acid with polyampholyte to complex; crosslinking polyampholyte; contacting with cell; gene therapy
08/29/2006	US7098030 Complexing polyampholyte containing an acid cleavable and polynucleotide; drug delivery; gene therapy
08/29/2006	US7098004 Isolated polypeptide of the stratum corneum and its use
08/29/2006	US7097868 Stable coated microcapsules
08/29/2006	US7097856 Dendrimeric support or carrier macromolecule
08/29/2006	US7097855 in situ addition polymerization of water soluble, biocompartible and biodegradable acrylic polymers, for drug delivery in tissue engineering
08/29/2006	US7097851 Multilayer capsule comprises an adhesion site-controlling layer for attaching to a selected site in the intestines, a drug-carrying layer, a protecting layer for preventing from digestive juice; improve bioavailability due to a low absorption in the digestive tract; dosage forms
08/29/2006	US7097849 Injectable aqueous dispersions of propofol
08/29/2006	US7097840 Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
08/29/2006	US7097839 A conjugated compound contains antibody or a Fab, and a radiostable therapeutic active agent; for diagnosis/therapy of colorectal cancer; biological conjugated drugs
08/29/2006	CA2402020C Pharmaceutical compositions
08/29/2006	CA2342390C Sustained release ranolazine formulations
08/29/2006	CA2342340C New sustained release oral formulations
08/29/2006	CA2271306C Pharmaceutical suspension systems
08/29/2006	CA2270177C Transdermal administration of ment
08/29/2006	CA2255615C Compositions comprising conjugates of cis-docosahexaenoic acid and docetaxel
08/29/2006	CA2255564C Aerodynamically light particles for pulmonary drug delivery
08/29/2006	CA2239183C Branched hydrazone linkers
08/29/2006	CA2111836C Spin-trapping pharmaceutical compositions and methods for use thereof
08/24/2006	WO2006089228A2 Conjugates of an epo moiety and a polymer
08/24/2006	WO2006089167A1 Glucosamine materials
08/24/2006	WO2006089007A2 Cyclodextrin-based polymers containing photocleavable linkers for drug delivery
08/24/2006	WO2006088576A2 Polypeptide formulations and methods for making, using and characterizing them
08/24/2006	WO2006088503A1 Delivery of enzymes to the brain
08/24/2006	WO2006088337A1 A base forming drug-layered silicate hybrid containing basic polymer and its synthesis method
08/24/2006	WO2006088336A1 Sustained release composition of protein drug
08/24/2006	WO2006088248A1 Polyoxyalkylene derivative
08/24/2006	WO2006088245A1 Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative
08/24/2006	WO2006088134A1 Method of relieving or avoiding side effect of steroid compound
08/24/2006	WO2006088102A1 Emulsifying agent derived from red yeast
08/24/2006	WO2006087968A1 Solid ophthalmic drug for external use
08/24/2006	WO2006087919A1 Finely divided composition containing poorly water soluble substance
08/24/2006	WO2006087354A2 Insulinotropic agents conjugated with structurally well defined branched polymers
08/24/2006	WO2006087312A1 Tablets comprising a biologically active substance and an excipient containing calcium carbonate
08/24/2006	WO2006087242A2 Intracellular inhibitor peptides and transgenic animals expressing same
08/24/2006	WO2006087178A1 Use of activated polymers for separation of protein and polypeptide multimers
08/24/2006	WO2006087028A1 Composition containing chitosan for sustained drug release
08/24/2006	WO2006086888A1 Compositions for treatment of diseases of the nail unit
08/24/2006	WO2006086870A1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier
08/24/2006	WO2006086864A1 Pharmaceutical compositions comprising aromatic solubilizing agents
08/24/2006	WO2006086862A1 Use of aromatic flavouring agents with high melting point as solubilizing agents
08/24/2006	WO2006076673A3 Use of il-i antagonists to treat polymyalgia rheumatica and giant cell arteritis
08/24/2006	WO2006065746A3 Methods of treating ige-mediated disorders comprising the administration of high concentration anti-ige antibody formulations
08/24/2006	WO2006061156A3 Medicament for hygienic application inside the ear
08/24/2006	WO2006056204A8 Method of cross-linking hyaluronic acid with divinylsulfone
08/24/2006	WO2006015154A3 Compositions and methods for nutrition supplementation
08/24/2006	WO2005110484A3 Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration
08/24/2006	WO2005094265A3 Self assembling activation agents targeted using active drug release
08/24/2006	WO2005074460A9 Methods of enhancing immune response in the intradermal compartment and compounds useful in the methods
08/24/2006	WO2005072061A3 Conjugates for cancer therapy and diagnosis
08/24/2006	WO2005067978A3 Thiopeptide conjugates for drug delivery
08/24/2006	WO2005065709A3 Lyophilized antibody conjugate formulation
08/24/2006	WO2004069134A8 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology
08/24/2006	WO2004016734A3 Nucleic acids and corresponding proteins entitled 282p1g3 useful in treatment and detection of cancer
08/24/2006	US20060189963 Multi-reservoir device for controlled drug delivery
08/24/2006	US20060189785 Using biocompatible, low molecular weighty, water solubler polymer; injectable
08/24/2006	US20060189696 Polyamine conjugates with acidic retinoids and preparation thereof
08/24/2006	US20060189695 External preparation for improving coital function
08/24/2006	US20060189683 Parenteral formulation of mycophenolic acid, a salt or prodrug thereof
08/24/2006	US20060189662 Novel liquid preparation
08/24/2006	US20060189574 Method of treating high plasma cholesterol levels
08/24/2006	US20060189573 Solutions and films of glycated chitosan
08/24/2006	US20060189572 Composition for local anesthesia
08/24/2006	US20060189558 Delivery of substances to cells
08/24/2006	US20060189544 Integrin-Mediated drug targeting
08/24/2006	US20060189500 Aqueous olanexidine solution, method of preparing the same, and disinfectant
08/24/2006	US20060188578 Hyaluronic acid nanoparticles

1 ... 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 ... 1712